CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 119 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,210,602 | -30.9% | 2,529,116 | +0.6% | 1.48% | -22.2% |
| Q2 2023 | $79,917,390 | +30.3% | 2,513,916 | 0.0% | 1.90% | +29.9% |
| Q1 2023 | $61,314,411 | -22.4% | 2,513,916 | +0.3% | 1.46% | -23.1% |
| Q4 2022 | $79,053,875 | +11.9% | 2,506,464 | +0.3% | 1.90% | +4.3% |
| Q3 2022 | $70,626,000 | +51.2% | 2,499,148 | +41.4% | 1.82% | +34.1% |
| Q2 2022 | $46,723,000 | -22.6% | 1,767,141 | +2.5% | 1.36% | -10.5% |
| Q1 2022 | $60,334,000 | +12.9% | 1,723,341 | +4.5% | 1.52% | +23.0% |
| Q4 2021 | $53,442,000 | +13.2% | 1,648,435 | +3.0% | 1.24% | +24.4% |
| Q3 2021 | $47,217,000 | +81.2% | 1,600,589 | +57.4% | 0.99% | +92.8% |
| Q2 2021 | $26,054,000 | +88.8% | 1,016,945 | +1.2% | 0.52% | +71.1% |
| Q1 2021 | $13,800,000 | -16.7% | 1,005,100 | +0.6% | 0.30% | -14.2% |
| Q4 2020 | $16,563,000 | – | 999,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |